Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Shorts Are Piling Into These Stocks. Should You Be Worried? Exelon Corporation (EXC), Hess Corp. (HES), Manulife Financial Corporation (USA) (MFC)

Earnings Analysis: Hess Corp. (NYSE: HES)The best thing about the stock market is that you can make money in either direction. Historically, stock indexes have tended to trend up over the long term. But when you look at individual stocks, you’ll find plenty that lose money over the long haul. According to hedge fund institution Blackstar Funds, even with dividends included, between 1983 and 2006, 64% of stocks underperformed the Russell 3000, a broad-scope market index.

A large influx of short sellers shouldn’t be a condemning factor to any company, but it could be a red flag from traders that something may not be as cut-and-dried as it appears. Let’s look at three companies that have seen a rapid increase in the number of shares sold short and see whether traders are blowing smoke or if their worry has some merit.

Company Short Increase Jan. 31 to Feb. 15 Short Shares as a % of Float
Exelon Corporation (NYSE:EXC) 69.1% 2.1%
Manulife Financial Corporation (USA)  (NYSE:MFC) 84.7% 0.6%
Hess Corp. (NYSE:HES) 69.5% 6.3%

Source: The Wall Street Journal .

Captain, we need more power!
It’s been a rough ride for Exelon Corporation (NYSE:EXC) shareholders, who have seen their holdings reduced by roughly two-thirds since mid-2008. A combination of the biggest recession to hit the country in 70 years coupled with a rapid deterioration in alternative energy fuel costs have put Exelon at a marked disadvantage.

Nuclear energy, for which Exelon is the largest supplier in the U.S., is pricier than any other form of energy, although rising natural gas prices and stabilizing coal prices in recent months are making that comparison a bit less stark. The key takeaway as to whether you think Exelon is a bloated pig or an amazing value has to do with its ability to generate demand for nuclear energy and if it can level the playing field by utilizing alternative energies of its own. To both fronts I’d say Exelon has a good shot at success.

In terms of alternative energy, Exelon Corporation (NYSE:EXC) is already working to actively boost its solar and wind production capacity, including a solar-farm project signed with First Solar, Inc. (NASDAQ:FSLR) in Maryland. Alternative energy projects like this cost a lot upfront, but their long-term effect is financially beneficial for shareholders, energy customers, and the environment.

I suspect Exelon will get its nuclear gap bridged sooner than later as President Obama’s U.S. energy independence initiatives will supply the nuclear industry with much-needed subsidies to keep building. If nuclear power, which is another form of clean energy, can receive a governmental boost, then Exelon Corporation (NYSE:EXC) should have no problem competing against low natural gas prices.

I’ll gladly pay you Tuesday for a higher Treasury yield today!
Short sellers in the life insurance and financial protection sector may want to double-think their positions after that considerably better-than-expected jobs report on Friday.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.